Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Gut Microbiome Composition Is Associated With Response to CD38 Antibody (Daratumumab) Treatment Among Relapsed Multiple Myeloma Patients.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 04, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival.
Journal: Transplantation and cellular therapy
Published: February 12, 2026
Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantation.
Journal: Diabetes, obesity & metabolism
Published: September 26, 2025
GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series.
Journal: Blood cancer journal
Published: April 28, 2025
CRISPR Knockdown of CHIP Genes in Macrophages Drives Increased Production of Inflammatory Cytokines in CAR-T Cell Therapy.
Journal: Transplantation and cellular therapy
Published: April 08, 2025
Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation.
Journal: Journal of the National Cancer Institute
Published: April 03, 2025
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma.
Journal: Annals of hematology
Published: June 17, 2024
Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration.
Journal: Frontiers in immunology
Published: April 26, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy.
Journal: Transplantation and cellular therapy
Published: April 10, 2024
Last Updated: 09/26/2026